Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02252 | 34446090 | Diabetol Metab Syndr | Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes. | 2021 | Details |
| A02253 | 34446002 | Lipids Health Dis | Sirtuin3 rs28365927 functional variant confers to the high risk of non-alcoholic fatty liver disease in Chinese Han population. | 2021 | Details |
| A02254 | 34445644 | Int J Mol Sci | Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome. | 2021 | Details |
| A02255 | 34445552 | Int J Mol Sci | Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02256 | 34445549 | Int J Mol Sci | Kaempferol and Kaempferide Attenuate Oleic Acid-Induced Lipid Accumulation and Oxidative Stress in HepG2 Cells. | 2021 | Details |
| A02257 | 34445384 | Int J Mol Sci | The Obscure Effect of Tribulus terrestris Saponins Plus Inulin on Liver Morphology, Liver Fatty Acids, Plasma Glucose, and Lipid Profile in SD Rats with and without Induced Type 2 Diabetes Mellitus. | 2021 | Details |
| A02258 | 34445195 | Int J Mol Sci | Immunonano-Lipocarrier-Mediated Liver Sinusoidal Endothelial Cell-Specific RUNX1 Inhibition Impedes Immune Cell Infiltration and Hepatic Inflammation in Murine Model of NASH. | 2021 | Details |
| A02259 | 34444932 | Nutrients | The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02260 | 34444811 | Nutrients | Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)-A Review. | 2021 | Details |
| A02261 | 34444807 | Nutrients | Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis. | 2021 | Details |
| A02262 | 34444750 | Nutrients | Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease. | 2021 | Details |
| A02263 | 34444683 | Nutrients | Differential Effects of Dietary Components on Glucose Intolerance and Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A02264 | 34444431 | Int J Environ Res Public Health | Inverse Association between Serum 25-hydroxyvitamin D Levels and Risk of Suspected Non-Alcoholic Fatty Liver Disease in Obese Population. | 2021 | Details |
| A02265 | 34443333 | Molecules | Phenolics-Rich Extracts of Dietary Plants as Regulators of Fructose Uptake in Caco-2 Cells via GLUT5 Involvement. | 2021 | Details |
| A02266 | 34442328 | J Pers Med | Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection. | 2021 | Details |
| A02267 | 34441497 | Foods | Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review. | 2021 | Details |
| A02268 | 34441028 | Medicina (Kaunas) | Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. | 2021 | Details |
| A02269 | 34441013 | Medicina (Kaunas) | Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification. | 2021 | Details |
| A02270 | 34440841 | Cells | Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02271 | 34440803 | Cells | NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome. | 2021 | Details |
| A02272 | 34440652 | Cells | Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis. | 2021 | Details |
| A02273 | 34440592 | Life (Basel) | The Association between Low Muscle Mass and Hepatic Steatosis in Asymptomatic Population in Korea. | 2021 | Details |
| A02274 | 34440543 | Life (Basel) | Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis. | 2021 | Details |
| A02275 | 34440507 | Life (Basel) | Association of Nonalcoholic Hepatic Fibrosis with Body Composition in Female and Male Psoriasis Patients. | 2021 | Details |
| A02276 | 34440495 | Life (Basel) | Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study. | 2021 | Details |
| A02277 | 34440260 | Biomedicines | The Histone Variant MacroH2A1 Impacts Circadian Gene Expression and Cell Phenotype in an In Vitro Model of Hepatocellular Carcinoma. | 2021 | Details |
| A02278 | 34439562 | Antioxidants (Basel) | Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 Cells. | 2021 | Details |
| A02279 | 34439491 | Antioxidants (Basel) | TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species. | 2021 | Details |
| A02280 | 34439474 | Antioxidants (Basel) | Garcinia cambogia Ameliorates Non-Alcoholic Fatty Liver Disease by Inhibiting Oxidative Stress-Mediated Steatosis and Apoptosis through NRF2-ARE Activation. | 2021 | Details |
| A02281 | 34439470 | Antioxidants (Basel) | Lupinus angustifolius Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE-/- Mice. | 2021 | Details |
| A02282 | 34439154 | Cancers (Basel) | A Novel Orthotopic Liver Cancer Model for Creating a Human-like Tumor Microenvironment. | 2021 | Details |
| A02283 | 34438269 | Ecotoxicol Environ Saf | Phthalates exposure is associated with non-alcoholic fatty liver disease among US adults. | 2021 | Details |
| A02284 | 34437908 | J Hepatol | Intestinal virome and therapeutic potential of bacteriophages in liver disease. | 2021 | Details |
| A02285 | 34437407 | Toxins (Basel) | Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans. | 2021 | Details |
| A02286 | 34435630 | J Clin Endocrinol Metab | TUBB3 E410K Syndrome With Childhood-Onset Nonalcoholic Steatohepatitis. | 2022 | Details |
| A02287 | 34435378 | Aliment Pharmacol Ther | Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH. | 2021 | Details |
| A02288 | 34435375 | Hepatology | A conventional immune regulator mitochondrial antiviral signaling protein blocks hepatic steatosis by maintaining mitochondrial homeostasis. | 2021 | Details |
| A02289 | 34435032 | ERJ Open Res | 1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease. | 2021 | Details |
| A02290 | 34434943 | Front Med (Lausanne) | Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update. | 2021 | Details |
| A02291 | 34434195 | Front Immunol | Caveolin-1 Deficiency Protects Mice Against Carbon Tetrachloride-Induced Acute Liver Injury Through Regulating Polarization of Hepatic Macrophages. | 2021 | Details |
| A02292 | 34434058 | Int J Gen Med | Elevated Serum Cyclophilin D Level is Associated with Nonalcoholic Fatty Liver Disease and Higher Fibrosis Scores in Patients with Diabetes Mellitus. | 2021 | Details |
| A02293 | 34433590 | BMJ Open | Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes. | 2021 | Details |
| A02294 | 34433546 | BMJ Open Diabetes Res Care | Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults. | 2021 | Details |
| A02295 | 34433228 | Hepatology | Up-regulation of thioesterase superfamily member 2 in skeletal muscle promotes hepatic steatosis and insulin resistance in mice. | 2021 | Details |
| A02296 | 34433051 | Cell Rep | Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria. | 2021 | Details |
| A02297 | 34432804 | PLoS One | Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study. | 2021 | Details |
| A02298 | 34432123 | Eur Radiol | Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis. | 2021 | Details |
| A02299 | 34431511 | Cochrane Database Syst Rev | Vitamin D supplementation for chronic liver diseases in adults. | 2021 | Details |
| A02300 | 34431493 | J Clin Endocrinol Metab | LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia. | 2022 | Details |
| A02301 | 34430188 | Cureus | In-Hospital Outcomes of Patients With Non-Alcoholic Fatty Liver Disease Who Underwent Percutaneous Coronary Intervention: A Nationwide Inpatient Sample Analysis. | 2021 | Details |
| A02302 | 34430140 | Cureus | Rapid Onset of Weight Gain and Liver Dysfunction Successfully Treated With Nutrition and Exercise. | 2021 | Details |
| A02303 | 34428046 | Mol Pharm | Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment. | 2021 | Details |
| A02304 | 34427948 | J Gastroenterol Hepatol | The associations between physical activity intensity, cardiorespiratory fitness, and non-alcoholic fatty liver disease. | 2021 | Details |
| A02305 | 34427662 | Clin Sci (Lond) | Exposure to cigarette smoke precipitates simple hepatosteatosis to NASH in high-fat diet fed mice by inducing oxidative stress. | 2021 | Details |
| A02306 | 34426744 | Evid Based Complement Alternat Med | Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver. | 2021 | Details |
| A02307 | 34426178 | J Integr Med | Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease. | 2021 | Details |
| A02308 | 34426127 | Chemosphere | Gestational exposure to high fat diets and bisphenol A alters metabolic outcomes in dams and offspring, but produces hepatic steatosis only in dams. | 2021 | Details |
| A02309 | 34426119 | Int Immunopharmacol | Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota. | 2021 | Details |
| A02310 | 34425199 | Int J Biochem Cell Biol | Sulfated glucuronomannan hexasaccharide G6S1 enhanced lipolysis and lipophagy via PPARα pathway. | 2021 | Details |
| A02311 | 34423721 | Expert Rev Gastroenterol Hepatol | Metabolic disorders and the risk of cholangiocarcinoma. | 2021 | Details |
| A02312 | 34423525 | Int J Clin Pract | Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: A randomised placebo-controlled clinical trial. | 2021 | Details |
| A02313 | 34423182 | ACS Omega | Effect of Silymarin and Quercetin in a Miniaturized Scaffold in Wistar Rats against Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A02314 | 34422459 | Cureus | Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02315 | 34422323 | J Clin Transl Sci | Excess dietary fructose does not alter gut microbiota or permeability in humans: A pilot randomized controlled study. | 2021 | Details |
| A02316 | 34422077 | Evid Based Complement Alternat Med | The Efficacy of Rosa damascena on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial. | 2021 | Details |
| A02317 | 34422075 | Evid Based Complement Alternat Med | Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways. | 2021 | Details |
| A02318 | 34421825 | Front Endocrinol (Lausanne) | Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02319 | 34421816 | Front Endocrinol (Lausanne) | Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
| A02320 | 34420934 | Gut Liver | Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A02321 | 34420885 | Hepatobiliary Pancreat Dis Int | Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study. | 2021 | Details |
| A02322 | 34419953 | Obes Facts | Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients. | 2021 | Details |
| A02323 | 34419589 | Biochim Biophys Acta Mol Cell Biol Lipids | Loss and gain of function of Grp75 or mitofusin 2 distinctly alter cholesterol metabolism, but all promote triglyceride accumulation in hepatocytes. | 2021 | Details |
| A02324 | 34419146 | Hereditas | Dynamic co-expression modular network analysis in nonalcoholic fatty liver disease. | 2021 | Details |
| A02325 | 34418914 | Endocrinol Metab (Seoul) | High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study. | 2021 | Details |
| A02326 | 34417811 | Endocrinology | Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity. | 2021 | Details |
| A02327 | 34417588 | Nat Rev Endocrinol | Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease. | 2021 | Details |
| A02328 | 34416976 | Gastroenterology | Preparing for the NASH Epidemic: A Call to Action. | 2021 | Details |
| A02329 | 34416350 | Toxicology | Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent. | 2021 | Details |
| A02330 | 34416040 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. | 2021 | Details |
| A02331 | 34415657 | J Viral Hepat | Prevalence of hepatitis E infection among adults with concurrent chronic liver disease. | 2021 | Details |
| A02332 | 34415481 | J Med Ultrason (2001) | Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease. | 2021 | Details |
| A02333 | 34414956 | Medicine (Baltimore) | Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients. | 2021 | Details |
| A02334 | 34414507 | Virchows Arch | Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. | 2021 | Details |
| A02335 | 34414181 | Front Cell Dev Biol | Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders. | 2021 | Details |
| A02336 | 34414123 | Liver Cancer | Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort. | 2021 | Details |
| A02338 | 34411916 | Biomed Pharmacother | The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression. | 2021 | Details |
| A02339 | 34411553 | Metabolism | Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea. | 2021 | Details |
| A02340 | 34411447 | EMBO Mol Med | Functional multispectral optoacoustic tomography imaging of hepatic steatosis development in mice. | 2021 | Details |
| A02341 | 34411400 | Liver Int | Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection. | 2021 | Details |
| A02342 | 34410623 | Hum Cell | Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression. | 2021 | Details |
| A02343 | 34410573 | Dig Dis Sci | A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02344 | 34410265 | J Pak Med Assoc | The frequency of non-alcoholic fatty liver disease in non-obese young medical professionals. | 2021 | Details |
| A02345 | 34409309 | STAR Protoc | A luminescence-based protocol for assessing fructose metabolism via quantification of ketohexokinase enzymatic activity in mouse or human hepatocytes. | 2021 | Details |
| A02346 | 34408183 | Sci Rep | Key features of the environment promoting liver cancer in the absence of cirrhosis. | 2021 | Details |
| A02347 | 34407600 | Diabetes Metab J | Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway. | 2021 | Details |
| A02348 | 34407548 | Exp Clin Endocrinol Diabetes | Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver Injury. | 2021 | Details |
| A02349 | 34406410 | J Clin Endocrinol Metab | The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD. | 2022 | Details |
| A02350 | 34406397 | J Mol Cell Biol | Multi-omics profiling: the way towards precision medicine in metabolic diseases. | 2021 | Details |
| A02352 | 34406209 | Braz J Med Biol Res | α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism. | 2021 | Details |
| A02353 | 34406004 | J Agric Food Chem | Baicalein Enhances the Effect of Acarbose on the Improvement of Nonalcoholic Fatty Liver Disease Associated with Prediabetes via the Inhibition of De Novo Lipogenesis. | 2021 | Details |